{"id":"W4379600190","doi":"10.1093/bjd/ljad182","title":"Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Probity Medical Research; Calgary Laboratory Services; SKiN Health","funders":"","keywords":"Scalp; Tolerability; Roflumilast; Medicine; Psoriasis; Randomized controlled trial; Clinical endpoint; Adverse effect; Randomization; Dermatology; Surgery; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00221801,0.001548645,0.003417982,0.0005352211,0.0004223162,0.001061878,0.00108596,0.00197226,0.009448228],"category_scores_gemma":[0.001311812,0.0008458319,0.001640233,0.0006081652,0.0008955358,0.0008898201,0.0002818196,0.002046443,0.001836509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005253272,"about_ca_system_score_gemma":0.001196144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008994203,"about_ca_topic_score_gemma":0.001718116,"domain_scores_codex":[0.9993902,0.0002887188,0.00004355382,0.000108223,0.00006221519,0.0001070105],"domain_scores_gemma":[0.9993587,0.0001510357,0.0001794822,0.00006118086,0.0000748742,0.0001747043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9398752,0.01621962,0.0004844976,0.001823695,0.001039991,0.00007217524,0.00007954161,0.0002818067,0.01149723,0.0001219846,0.001886709,0.02661753],"study_design_scores_gemma":[0.9537834,0.04389637,0.0008711864,0.00003938365,0.0002699134,0.00003413833,0.00001221585,0.0001752834,0.0002816815,0.00005103399,0.0005769863,0.00000851088],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9531961,0.01444941,0.002758328,0.001129832,0.0007715073,0.01933357,0.003069456,0.0006099305,0.004681839],"genre_scores_gemma":[0.950833,0.01088896,0.00466529,0.002552675,0.0007601713,0.02120247,0.002675768,0.0001005911,0.006320965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009448228,"threshold_uncertainty_score":0.03160751,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02527273897059209,"score_gpt":0.2932965594720684,"score_spread":0.2680238205014763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}